SecBot SecBot
EFFECT ·Filed Apr 27, 2026

CINGW

Cingulate Inc.
BEARISH
Impact 6/10
Horizonweeks Processed6mo ago SEC9999999995-26-001327
IPO/offering going effective
Actionable Insight ▼ Bearish

Monitor for near-term insider or investor selling under this shelf, which could pressure shares. Watch for warrant exercises, which may provide limited cash inflow but further dilute equity. Given Cingulate's history of dilutive financings and prior going concern risks, this shelf adds to overhang without strengthening the balance sheet directly.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CINGW ▼ -68.55% at T+60d
SHORT call ✓ call won +68.55% · α vs SPY +73.33% · entry $0.0601 → $0.0189
Entry = T+0 close
Apr 27, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.49%
$0.0601
settled 6mo ago
T+5d
0.00%
call 0.00% · α +0.40%
$0.0601
settled 6mo ago
T+20d
-68.39%
call +68.39% · α +73.34%
$0.0190
settled 5mo ago
T+60d
-68.55%
call +68.55% · α +73.33%
$0.0189
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Cingulate Inc.'s S-3 shelf registration has become effective, allowing the company and selling stockholders to offer up to 4,208,711 shares of common stock from a prior private placement. The company will not receive proceeds from the resale of these shares, though it may receive funds if warrants are exercised on a cash basis.

Key Facts

  • S-3 shelf registration (File No. 333-295050) became effective on April 24, 2026.
  • Registration covers resale of 4,208,711 shares held by selling stockholders from a January 2026 private placement.
  • Shares include those issued directly, upon conversion of Series A preferred stock, and issuable upon warrant exercise.
  • Cingulate will not receive proceeds from resale, but may receive cash if warrants are exercised non-cashlessly.
  • This is the third S-3 filing in 2026, indicating ongoing reliance on capital markets.

Financial Impact

Potential dilution from up to 4.2 million shares; proceeds from warrant exercises possible but amount undisclosed.

dilutioncash

Risk Factors

  • Equity dilution from resale of 4.2 million shares
  • Downward price pressure from selling stockholders liquidating positions
  • No direct proceeds to company exacerbates cash-constrained operations

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001327
Document: 9999999995-26-001327-index.html9999999995-26-001327
Document: 9999999995-26-001327.txt9999999995-26-001327
6 reports for CINGW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CINGW — sortable, filterable
TypeNow
Jun 2, 2026
20w ago
8-K
BEARISH ★ 7/10
$0.0601 $0.0114▲ +81.03%▲ +82.15%—
May 19, 2026
22w ago
8-K
NEUTRAL ★ 2/10
$0.0601 $0.007200▼ −88.02%▼ −93.02%—
May 14, 2026
23w ago
8-K
NEUTRAL ★ 5/10
$0.0601 $0.007200▼ −88.02%▼ −91.61%—
May 14, 2026
23w ago
Press Release
NEUTRAL ★ 5/10
$0.0601 $0.007200▼ −88.02%▼ −91.61%—
Apr 27, 2026
26w ago
EFFECT
BEARISH ★ 6/10
$0.0601 $0.0189▲ +68.55%▲ +73.33%—
Mar 18, 2026
31w ago
Press Release
MIXED ★ 6/10
$0.0601 $0.0601· 0.00%▼ −11.53%—
Showing 6 of 6

US Market Status

Market Open — Closes in 5h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 27, 2026